Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets. - Wikidata - awgldk - TriplyDB

Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

http://www.wikidata.org/entity/Q30398271

about

Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets 3-Hydroxyquinolin-2(1 H )-ones As Inhibitors of Influenza A Endonuclease Engineering H5N1 avian influenza viruses to study human adaptation Influenza viruses: breaking all the rules Estimating the fitness advantage conferred by permissive neuraminidase mutations in recent oseltamivir-resistant A(H1N1)pdm09 influenza viruses Two years after pandemic influenza A/2009/H1N1: what have we learned?Phenyl substituted 4-hydroxypyridazin-3(2H)-ones and 5-hydroxypyrimidin-4(3H)-ones: inhibitors of influenza A endonuclease.Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.Integrated Omics Analysis of Pathogenic Host Responses during Pandemic H1N1 Influenza Virus Infection: The Crucial Role of Lipid Metabolism.A Novel Endonuclease Inhibitor Exhibits Broad-Spectrum Anti-Influenza Virus Activity In Vitro A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase.The host interactome of influenza virus presents new potential targets for antiviral drugs.Multidrug resistant 2009 A/H1N1 influenza clinical isolate with a neuraminidase I223R mutation retains its virulence and transmissibility in ferrets Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium.Fitness of neuraminidase inhibitor-resistant influenza A viruses Comparable fitness and transmissibility between oseltamivir-resistant pandemic 2009 and seasonal H1N1 influenza viruses with the H275Y neuraminidase mutation.The H275Y neuraminidase mutation of the pandemic A/H1N1 influenza virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets.Consequences of resistance: in vitro fitness, in vivo infectivity, and transmissibility of oseltamivir-resistant influenza A viruses.Evaluation of recombinant 2009 pandemic influenza A (H1N1) viruses harboring zanamivir resistance mutations in mice and ferrets.Decoding the distribution of glycan receptors for human-adapted influenza A viruses in ferret respiratory tract.Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.Influenza neuraminidase.In vivo evaluation of pathogenicity and transmissibility of influenza A(H1N1)pdm09 hemagglutinin receptor binding domain 222 intrahost variants isolated from a single immunocompromised patient Antigen-activated dendritic cells ameliorate influenza A infections N-acylhydrazone inhibitors of influenza virus PA endonuclease with versatile metal binding modes.Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.Impact of potential permissive neuraminidase mutations on viral fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus in vitro, in mice and in ferrets.Using mutagenesis to explore conserved residues in the RNA-binding groove of influenza A virus nucleoprotein for antiviral drug development.Investigation of the salicylaldehyde thiosemicarbazone scaffold for inhibition of influenza virus PA endonuclease.Porphyrin-based cationic amphiphilic photosensitisers as potential anticancer, antimicrobial and immunosuppressive agents Characterization of drug-resistant influenza A(H7N9) variants isolated from an oseltamivir-treated patient in Taiwan.

P2860

Q27334946-F5EEF303-AE01-472E-9336-255DE138A01E Q27684365-C5B94BA1-5A5C-4152-9190-B67256A6F5BA Q28386710-43DB376D-6218-4175-81F5-1F237FC1F34C Q28386965-87289900-4040-4E90-BA42-26ADAB3046F0 Q28541953-7C47C80A-9870-468F-94EE-E18DCB59B496 Q30224656-8405D7D5-DD28-4711-8AA7-15A90DB48B00 Q30366846-60A99B3E-5F19-48AE-94E9-6AA8F2F29395 Q30367861-1ED72833-B7D6-44EE-A8AE-925A5E0E33F3 Q30384349-7078F9A7-5D0D-431E-9A6D-5BC1283E9826 Q30390167-5D774DD5-7690-4EC1-B1B4-B6A598FA1921 Q30405350-01690F51-82A3-4906-83E5-67F4455EA406 Q30405769-609711D9-CB52-47D0-AC83-9590A3BF94F2 Q30407925-51669E56-6E90-4C22-9314-1E4E82D10D92 Q30413246-9556A509-3060-479A-861F-4CEAC7615C55 Q30413673-196D2897-1BAA-4E21-9466-17D18A96C090 Q30414559-3CB7ABF4-0136-422A-84C0-0A30510DC108 Q30419391-7C860F0C-2185-4ADB-9F30-5799D0A2C2C8 Q30419738-930D0E82-A620-40E8-832B-689C3C5D4E3E Q30425354-FB48DECC-15EB-447F-882E-AF8418FF00F7 Q30426441-C40975B8-D8E3-40CD-B24A-22FB8F6C4EF4 Q34167968-03D5342C-FC9B-4631-98C9-EF67F88CA13F Q35139986-5658E541-8D5E-4FBF-915F-714BC40DE884 Q35791130-39B450AA-5C3D-4547-9367-DADA70A8F2CE Q35954143-289E151B-B4E0-464C-AEB4-5A010B158A3C Q36966984-779025E9-BE84-40DD-9241-6536D5A508C6 Q37166751-49658D23-578D-4FAF-B8FB-26ADECE1E739 Q37394266-3C62B844-4B5B-45E4-8F17-FCC8C2BF4B6F Q37547236-12B98004-121D-4563-BA9E-31072AE7CAC6 Q38641540-A1A074A1-23DC-4175-AABF-D360EDFB9C35 Q38839349-10C9210D-B41E-44DC-91BE-769AAC4E8DD8 Q39310603-2C4700A0-44B4-4098-B4AE-962B144FE069 Q42199847-FC49427D-563A-4D62-A446-CFF971C01D26

P2860

Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.

http://www.wikidata.org/entity/Q30398271

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@ast

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@en

type

label

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@ast

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@en

prefLabel

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@ast

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@en

P1433

Q30398271-7ABBBF76-4520-4DDF-8999-73F40C0C2B42

P1476

Q30398271-B8B90BEE-43EF-4E02-A28A-89C1C7F32051

P2093

Q30398271-44A1913D-F60A-4519-9A45-735F7EE8DE40

Q30398271-67D251C4-2362-4B71-BBDE-D97C82DBA6DF

Q30398271-9A0ABE8F-D921-42EC-9952-F71AB9357421

Q30398271-E090332B-3571-4D6A-90FD-2853E4AA3CE2

Q30398271-E33ED53F-D4A0-41DC-ACFB-D420FDE9E607

P2860

Q30398271-04A9AB77-C5F9-4170-ACF2-0866D3A2874A

Q30398271-060F3B81-5A78-4098-8481-7F7047EE8ACA

Q30398271-10117C19-B8A2-42B3-9487-0700C4210C00

Q30398271-113215EC-34E6-4865-83D6-476B38699465

Q30398271-156D733F-CF96-421C-8276-A2288A459897

Q30398271-1996A7C5-C626-4A0B-AC7F-76168A7FD434

Q30398271-2C4F990E-1856-4275-8D4D-D3689643F64A

Q30398271-2CF53698-0EE5-4B56-AD7F-B9E679EE7767

Q30398271-2EF44F29-FF43-4C28-85DD-BFBDDBA3F806

Q30398271-324EA49E-D5C1-41C2-9A70-5EB118FF6D2B

P304

Q30398271-3691DD02-0550-467E-80B3-1BBD88516CAE

P31

Q30398271-08A29125-44AC-4F5B-B41F-1171BBCD0552

P356

Q30398271-FE0CA7DA-401A-4F51-8656-1FEEC6CA593C

P407

Q30398271-1E83A811-A3B7-47FB-9F72-5DEB0AD4E238

P433

Q30398271-DABC55D2-E9A6-4B39-9521-978991BA1C08

P478

Q30398271-A827E644-EDD4-4AD4-93AD-D5D36545E584

P50

Q30398271-855EC63B-A95C-4574-ABBE-37B0D8A0C463

Q30398271-87778B67-39B9-43E9-854D-1E9606448BEC

P577

Q30398271-BE8CF7BA-B9FC-4E81-8B3B-19D7A836C424

P5875

Q30398271-B56D40F1-2779-4847-BD07-C2854CAAC307

P698

Q30398271-E098B4BD-6FF2-4657-8A19-374DE3EEAE86

P921

Q30398271-625BDAF1-6918-4BA6-B119-CF81D8566D09

Q30398271-6E5A81C8-A86E-4062-87DC-39423C718CEF

P932

Q30398271-A1485AC5-8230-4C01-88E8-10F2BED66F35

P356

P1433

The Journal of Infectious Diseases

P1476

Multidrug-resistant 2009 pande ...... d transmissibility in ferrets.

@en

P2093

A Sally Davis

http://www.w3.org/2001/XMLSchema#string

Daniel S Chertow

http://www.w3.org/2001/XMLSchema#string

Kathleen Proudfoot

http://www.w3.org/2001/XMLSchema#string

Rachel J Hrabal

http://www.w3.org/2001/XMLSchema#string

Tyler Bristol

http://www.w3.org/2001/XMLSchema#string

P2860

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS 4071.

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir.

An early 'classical' swine H1N1 influenza virus shows similar pathogenicity to the 1918 pandemic virus in ferrets and mice.

Update: influenza activity - United States, August 30-October 31, 2009.

Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections

Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts

P304

348-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIQ067

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

203

http://www.w3.org/2001/XMLSchema#string

P50

Jeffery Taubenberger

Matthew J Memoli

P577

2010-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49731398

http://www.w3.org/2001/XMLSchema#string

P698

21208927

http://www.w3.org/2001/XMLSchema#string

P921

multiple drug resistance

P932

3071106

http://www.w3.org/2001/XMLSchema#string